Explore the categories so you can find more about your search.

Categorie > Headache / Migraine

MAP Pharmaceuticals Reports Positive Phase 2 Results For Its Inhaled Migraine Drug Candidate

Categorie : Headache / Migraine
MAP Pharmaceuticals, Inc. announced today that its Tempo(TM) Migraine drug candidate met its primary endpoints in a Phase 2 clinical program consisting of two separate trials. The candidate is a proprietary orally inhaled formulation of dihydroergotamine (DHE) for the treatment of acute migraine. ...

read more MAP Pharmaceuticals, Inc. announced today that its Tempo(TM) Migraine drug candidate met its primary endpoints in a Phase 2 clinical program consisting of two separate trials. The candidate is a proprietary orally inhaled formulation of dihydroergotamine (DHE) for the treatment of acute migraine. read more Fri Mar 2007 Fri Mar 2007

High Blood Pressure Linked To Painkillers

Categorie : Headache / Migraine
American researchers have shown that men who use painkillers frequently risk higher blood pressure compared to those that do not.The study is published in the journal Archives of Internal Medicine.The team that did the research is from Brigham and Women's Hospital, Harvard Medical School and Harvard ...

read more American researchers have shown that men who use painkillers frequently risk higher blood pressure compared to those that do not.The study is published in the journal Archives of Internal Medicine.The team that did the research is from Brigham and Women's Hospital, Harvard Medical School and Harvard read more Wed Feb 2007 Wed Feb 2007

TorreyPines Therapeutics Initiates Second Phase I Clinical Trial Of NGX426, A Potential Novel Oral Treatment For Chronic Pain Conditions

Categorie : Headache / Migraine
TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced that it has initiated a second Phase I clinical trial of NGX426, a novel product candidate intended to treat chronic pain conditions such as migraine and neuropathic pain. NGX426 is an oral prodrug of tezampanel, the company's parenteral ...

read more TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced that it has initiated a second Phase I clinical trial of NGX426, a novel product candidate intended to treat chronic pain conditions such as migraine and neuropathic pain. NGX426 is an oral prodrug of tezampanel, the company's parenteral read more Tue Feb 2007 Tue Feb 2007

New Instrument Developed To Measure Impact Of Migraine On Patients' Lives When They Are Not Experiencing An Attack

Categorie : Headache / Migraine
The intense throbbing and disabling physical pain that is the hallmark of a migraine attack may not be the only disruption sufferers endure. There may also be an impact of migraine that patients experience when they are not having an attack, often termed interictal burden. [click link for full artic ...

read more The intense throbbing and disabling physical pain that is the hallmark of a migraine attack may not be the only disruption sufferers endure. There may also be an impact of migraine that patients experience when they are not having an attack, often termed interictal burden. [click link for full artic read more Sun Feb 2007 Sun Feb 2007

Par Pharmaceutical Receives Approval Of Generic Inderal-LA(R)

Categorie : Headache / Migraine
Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced it has received final approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for propranolol hydrochloride (HCl) extended release (ER) capsules in 60-, 80-, 120- and 160 mg dosage strengths. [click l ...

read more Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced it has received final approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for propranolol hydrochloride (HCl) extended release (ER) capsules in 60-, 80-, 120- and 160 mg dosage strengths. [click l read more Tue Jan 2007 Tue Jan 2007

Women With Migraines More Likely To Have Depression

Categorie : Headache / Migraine
Women with chronic headache, especially migraines, are more likely to be depressed, feel tired, and have a host of other severe physical symptoms, according to a study published in the January 9, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.The study involved ...

read more Women with chronic headache, especially migraines, are more likely to be depressed, feel tired, and have a host of other severe physical symptoms, according to a study published in the January 9, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.The study involved read more Thu Jan 2007 Thu Jan 2007

Women Who Have Migraine Are More Likely To Get Depressed

Categorie : Headache / Migraine
A new study by US scientists reveals that women who get chronic headaches or migraine are the most likely to suffer depression and other somatic symptoms like fatigue, joint pain and insomnia.The study is published in the current edition of the journal of the American Academy of Neurology Neurology. ...

read more A new study by US scientists reveals that women who get chronic headaches or migraine are the most likely to suffer depression and other somatic symptoms like fatigue, joint pain and insomnia.The study is published in the current edition of the journal of the American Academy of Neurology Neurology. read more Wed Jan 2007 Wed Jan 2007

Headaches Form Over A Possible New Form Of Aspirin

Categorie : Headache / Migraine
New scientific insights into the packaging of molecules in solids may tempt jokesters to add a second line to that old medical axiom, "Take two aspirin and call me in the morning." Insiders familiar with an unfolding controversy about aspirin -- more than 100 billion tablets of which are produced wo ...

read more New scientific insights into the packaging of molecules in solids may tempt jokesters to add a second line to that old medical axiom, read more Wed Jan 2007 Wed Jan 2007

Fear Of Migraine Destroys Quality Of Life For Men

Categorie : Headache / Migraine
The unpredictability of symptoms and apprehension associated with living with migraine is limiting mens' lives, according to research from Griffith University's Genomics Research Centre.Although migraine is more common in women than men, about 6% of Australian men live with the debilitating neurolog ...

read more The unpredictability of symptoms and apprehension associated with living with migraine is limiting mens' lives, according to research from Griffith University's Genomics Research Centre.Although migraine is more common in women than men, about 6% of Australian men live with the debilitating neurolog read more Mon Dec 2006 Mon Dec 2006

New Data Show Consistent Efficacy And Tolerability Of Trexima(R) (sumatriptan Succinate/naproxen Sodium) Across Multiple Migraine Attacks

Categorie : Headache / Migraine
New data examining more than 4,200 migraine attacks in more than 1,100 patients demonstrated that Trexima delivered consistent efficacy over multiple migraine attacks. The findings, presented today at the 16th Migraine Trust International Symposium in London, suggest Trexima may address an unmet nee ...

read more New data examining more than 4,200 migraine attacks in more than 1,100 patients demonstrated that Trexima delivered consistent efficacy over multiple migraine attacks. The findings, presented today at the 16th Migraine Trust International Symposium in London, suggest Trexima may address an unmet nee read more Fri Dec 2006 Fri Dec 2006

Scottish Medicines Consortium (SMC) Approves Topamax(R) For Prevention Of Migraine

Categorie : Headache / Migraine
A significant new treatment option to prevent migraine headaches is now available in Scotland following Monday's approval of TOPAMAX(R) (topiramate) by The Scottish Medicines Consortium (SMC)1.Unlike acute medicines that are taken at the onset of a migraine, daily migraine preventative therapy can r ...

read more A significant new treatment option to prevent migraine headaches is now available in Scotland following Monday's approval of TOPAMAX(R) (topiramate) by The Scottish Medicines Consortium (SMC)1.Unlike acute medicines that are taken at the onset of a migraine, daily migraine preventative therapy can r read more Fri Dec 2006 Fri Dec 2006

Give Yourself A Gift This Season: Send Your Migraine Packing

Categorie : Headache / Migraine
Thinking about the holidays may bring to mind smiling faces, nights by a warm fire, delicious holiday treats, endless presents and time away from your daily routine. But for some people, the holidays can cause stress with the last-minute shopping, hours of cooking, late nights of celebration, schedu ...

read more Thinking about the holidays may bring to mind smiling faces, nights by a warm fire, delicious holiday treats, endless presents and time away from your daily routine. But for some people, the holidays can cause stress with the last-minute shopping, hours of cooking, late nights of celebration, schedu read more Mon Dec 2006 Mon Dec 2006

Teva Announces Tentative Approval Of Sumatriptan Succinate Tablets

Categorie : Headache / Migraine
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Sumatriptan Succinate Tablets, 25 mg, 50 mg and 100 mg. Final approval is expected upon expiry of ...

read more Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Sumatriptan Succinate Tablets, 25 mg, 50 mg and 100 mg. Final approval is expected upon expiry of read more Fri Dec 2006 Fri Dec 2006

OHSU School Of Dentistry Team Discovers Potential New Target For Treating Craniofacial Pain Problems

Categorie : Headache / Migraine
A new study, published in the Journal of Neurochemistry, identifies a key interaction between head and neck nerve cell proteins that may help shed light on migraines and temporomandibular joint disordersResearchers at Oregon Health & Science University's School of Dentistry (http://www.ohsu. [click ...

read more A new study, published in the Journal of Neurochemistry, identifies a key interaction between head and neck nerve cell proteins that may help shed light on migraines and temporomandibular joint disordersResearchers at Oregon Health & Science University's School of Dentistry (http://www.ohsu. [click read more Thu Nov 2006 Thu Nov 2006

Brain Changes In Patients With Migraine

Categorie : Headache / Migraine
Researchers from Harvard Medical School have found increased thickness of two areas of the brain cortex in people with migraine when compared to healthy controls. Both areas of the brain are known to be involved in how the brain processes signals to do with movement.Using two forms of magnetic reson ...

read more Researchers from Harvard Medical School have found increased thickness of two areas of the brain cortex in people with migraine when compared to healthy controls. Both areas of the brain are known to be involved in how the brain processes signals to do with movement.Using two forms of magnetic reson read more Fri Oct 2006 Fri Oct 2006

TorreyPines Therapeutics Initiates Phase IIb Clinical Trial In Acute Migraine For Lead Compound Tezampanel

Categorie : Headache / Migraine
TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced the initiation of a Phase IIb clinical trial for its lead product candidate, tezampanel, a novel pain compound in development for the treatment of acute migraine. An AMPA/kainate (AK) receptor antagonist, tezampanel offers a non-narcotic ...

read more TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced the initiation of a Phase IIb clinical trial for its lead product candidate, tezampanel, a novel pain compound in development for the treatment of acute migraine. An AMPA/kainate (AK) receptor antagonist, tezampanel offers a non-narcotic read more Wed Oct 2006 Wed Oct 2006

European Headache Alliance Announces First European Migraine Day Of Action

Categorie : Headache / Migraine
Awareness of the pain and prejudice of living with migraine, a neurological condition that causes disabling headaches, is to receive a rallying call when patient groups from throughout Europe join forces for the launch of the European Headache Alliance, on the first ever European Migraine Day of Act ...

read more Awareness of the pain and prejudice of living with migraine, a neurological condition that causes disabling headaches, is to receive a rallying call when patient groups from throughout Europe join forces for the launch of the European Headache Alliance, on the first ever European Migraine Day of Act read more Sat Sep 2006 Sat Sep 2006

Migraine Treatment And Prevention In Women

Categorie : Headache / Migraine
Migraines are more common in the United States than diabetes, osteoarthritis or asthma. Of the 28 million people who experience migraines in this country, 18 million are women. Although prevention is very effective in managing this disorder, only 3 percent to 5 percent of women seek preventive thera ...

read more Migraines are more common in the United States than diabetes, osteoarthritis or asthma. Of the 28 million people who experience migraines in this country, 18 million are women. Although prevention is very effective in managing this disorder, only 3 percent to 5 percent of women seek preventive thera read more Sun Sep 2006 Sun Sep 2006

Headache / Migraine News from Medical News Today

Categorie : Headache / Migraine
Latest Headache / Migraine news updated throughout the day, every day ...

read more Latest Headache / Migraine news updated throughout the day, every day read more Tue Aug 2006 Tue Aug 2006

NatureWell, Incorporated To Attend Annual American Association Of Naturopathic Physician Convention In Portland

Categorie : Headache / Migraine
NatureWell, Incorporated(the "Company") (OTC Bulletin Board: NAWL), announced today that it will bean exhibitor at the American Association of Naturopathic Physicians (AANP)Annual Convention in Portland, Oregon on August 10-12, 2006, where it willbe marketing its natural migraine medication, MigraS ...

read more NatureWell, Incorporated(the read more Mon Aug 2006 Mon Aug 2006

<<< previous | 1 | 2 | 3 | 4 | 5 next >>>



     


Custom Search